IGF1 and hepatocellular carcinoma: In this article, we summarize the abnormal activity of IGF/IGF-1R signaling in HCC, the limitations of current targeted therapies for advanced HCC, and drugs that target IGF/IGF-1R signaling for the treatment of specific HCC.